ICUI Overview

ICU Medical, Inc. develops, manufactures and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume intravenous (IV) pumps and safety software, dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, sharps safety products, and sterile IV solutions. Its product offerings also include Consumables, Infusion Systems and Vital Care. Its consumables business unit includes infusion therapy, oncology, vascular access and tracheostomy products. Its infusion systems offer a portfolio of infusion pumps, software and professional services. Its vital care business unit includes, hemodynamic monitoring, general anesthesia and respiratory, temperature management solutions and regional anesthesia/pain management products. Its infusion therapy products include infusion sets, extension sets, needle-free connectors, and disinfection caps.

Wall Street analysts forecast ICUI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ICUI is173.50 USD with a low forecast of 172.00 USD and a high forecast of 175.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

ICU Medical Inc revenue for the last quarter amounts to 540.70M USD, decreased -14.15

ICU Medical Inc. EPS for the last quarter amounts to -0.64 USD, decreased -34.02

ICU Medical Inc (ICUI) has 13000 emplpoyees as of April 01 2026.

Today ICUI has the market capitalization of 3.19B USD.